ArticleDrug safety2021

Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin.

Efe Eworuke et al.PubMed ↗Publisher ↗

No numbers read from the abstract.